We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $1.85M
1-Year Est. Return 176.16%
This Fund
S&P 500
This Quarter Est. Return
+9.05%
1 Year Est. Return
+176.16%
3 Year Est. Return
+511.75%
5 Year Est. Return
+854.95%
10 Year Est. Return
+8,566.11%
AUM
$1.85M
AUM Growth
-$2.17M
Cap. Flow
-$2.64M
Cap. Flow %
-142.5%
Top 10 Hldgs %
100%
Holding
11
New
4
Increased
2
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$249K
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$226K
3
BX icon
Blackstone
BX
+$192K
4
LXEO icon
Lexeo Therapeutics
LXEO
+$16.3K
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$13K

Top Sells

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$3.28M
2
KYTX icon
Kyverna Therapeutics
KYTX
+$57K

Sector Composition

Rank Sector Weight
1 Miscellaneous 36.6%
2 Financials 30.5%
3 Healthcare 19.57%
4 Communication Services 13.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPCX
1
PUT
SpaceX
SPCX
$1.97T
$445K 24.03%
+2,606
New +$443K
BRK.B icon
2
Berkshire Hathaway Class B
BRK.B
$1.09T
$377K 20.35%
754
+27
+4% +$13K
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$4.19T
$247K 13.32%
+691
New +$249K
VOO icon
4
Vanguard S&P 500 ETF
VOO
$1.03T
$233K 12.58%
+339
New +$226K
BX icon
5
Blackstone
BX
$103B
$188K 10.16%
+1,597
New +$192K
KYTX icon
6
Kyverna Therapeutics
KYTX
$516M
$110K 5.94%
12,347
-6,426
-34% -$57K
LXEO icon
7
Lexeo Therapeutics
LXEO
$397M
$79K 4.26%
16,962
+3,019
+22% +$16.3K
XFOR icon
8
X4 Pharmaceuticals
XFOR
$401M
$72.7K 3.92%
15,557
– –
IKT icon
9
Inhibikase Therapeutics
IKT
$352M
$57.8K 3.12%
28,453
– –
ALXO icon
10
ALX Oncology
ALXO
$281M
$43.4K 2.34%
20,946
– –
GLD icon
11
SPDR Gold Trust
GLD
$150B
– –
-7,623
Closed -$3.28M

Similar funds

1IC
1922 Investment Company Houston, Texas $1.89M AUM 15.39% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $1.91M AUM 81.42% 1-Year Est. Return
HGCK
HPC Germany & Co KG Potsdam, Germany $1.68M AUM 15.3% 1-Year Est. Return
CA
Cohalo Advisory Snoqualmie, Washington $1.65M AUM 11.44% 1-Year Est. Return
CAM
Creekmur Asset Management Morton, Illinois $2.07M AUM
FLC
Fifth Lane Capital Austin, Texas $1.63M AUM 7.3% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $1.56M AUM 25.68% 1-Year Est. Return
DCM
Dupont Capital Management Wilmington, Delaware $2.18M AUM 50.81% 1-Year Est. Return

Caxton Corporation's Q2 2026 Portfolio in Review

As of Q2 2026, Caxton Corporation held 11 positions worth $1.85M, down 54% from $4.02M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Caxton Corporation withdrew a net $2.64M in Q2 2026, closing 1 position and reducing 1 holding. Its most notable exit was SPDR Gold Trust, an estimated $3.28M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, down from 82% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Caxton Corporation opened a new position in Alphabet (Google) Class A worth $247K.

  • Caxton Corporation's largest Q2 2026 buy was Alphabet (Google) Class A: 691 shares worth $247K.
  • Caxton Corporation added most to Lexeo Therapeutics in Q2 2026, an estimated $16.3K increase.
  • Caxton Corporation's biggest Q2 2026 reduction was Kyverna Therapeutics, cutting an estimated $57K.
  • Caxton Corporation fully exited SPDR Gold Trust in Q2 2026, selling an estimated $3.28M.
  • Caxton Corporation's ten largest holdings make up 100% of its $1.85M portfolio in Q2 2026.
  • Caxton Corporation opened 4 new positions and closed 1 in Q2 2026.
  • Caxton Corporation's portfolio value fell 54% quarter-over-quarter to $1.85M.

Based on Caxton Corporation's 13F filing for Q2 2026, filed 14 Aug 2026.